SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (82)8/3/1999 1:56:00 PM
From: Harold Engstrom   of 427
 
Peter,

Was stunned to read that TS.C article a few weeks ago: I had taken them up on their free trial period and that was the first article I read. At the time, I couldn't decide which person was the bigger dolt: Kimmel for making the comment or Greenberg for quoting him. Upon seeing his response to the many emails that set him straight (where he just reiterated what Kimmel said), it was clear Greenberg deserved the prize.

I'm with you: SEPR holds huge potential and I believe that it is just a matter of time before it absolutely explodes to the upside. But, when people increasingly believe 6 months is a long time to hold a stock, 3 years seems an eternity. But, that is the great thing about biotech investing: the myopic vision of the general investing community gives rise to great opportunity for those who have some patience and are willing to learn something about how these companies operate and about the indications their products will treat.

I do believe that SEPR is one of the coming stars of this industry. However, it is the exception. There are companies like GLIA and CLTR and SEPR and then there are the majority of small-to-mid-sized biotechs that probably will not make it. I agree that a short position does not usually mean everyone else just doesn't get it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext